A critical evaluation of internet marketing of products that contain ephedra

Mayo Clinic Proceedings

Volumn 78, Issue 8, 2003, Pages 944-946

  Ashar, Bimal H ^a   Miller, Redonda G ^a   Getz, Kelly J ^a   Pichard, Carmen P ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EPHEDRA EXTRACT;

ARTICLE; DIET SUPPLEMENTATION; DRUG CONTRAINDICATION; DRUG INFORMATION; DRUG MARKETING; EPHEDRA; FOOD AND DRUG ADMINISTRATION; INTERNET; WEIGHT REDUCTION;

EID: 0042206866     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/78.8.944     Document Type: Article

References (18)

1. Haller CA, Benowitz NL. Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids. N Engl J Med. 2000;343:1833-1838.
2. Samenuk D, Link MS, Homoud MK, et al. Adverse cardiovascular events temporally associated with ma huang, an herbal source of ephedrine. Mayo Clin Proc. 2002;77:12-16.
3. Blanck HM, Khan LK, Serdula MK. Use of nonprescription weight loss products: results from a multistate survey. JAMA. 2001;286: 930-935.
4. Nowak D, Zlatic T. Herbal products and the Internet: a marriage of convenience. J Am Pharm Assoc (Wash). 1999;39:241-242.
5. Taylor SE, Feld HJ. Promoting functional foods and nutraceuticals on the Internet. Food Drug Law J. 1999;54:423-451.
6. Sullivan P. Internet a prime venue for snake-oil sales of "health products." CMAJ. 2001;165:465.
7. Committee on Labor and Human Resources. Report on Dietary Supplement Health and Education Act of 1994. Washington, DC: United States Senate; 1994. Publication 103-410.
8. Ma huang. Available at: www.micromedex.com. Accessed July 30, 2002.
9. Astrup A, Breum L, Toubro S, Hein P, Quaade F. The effect and safety of an ephedrine/caffeine compound compared to ephedrine, caffeine and placebo in obese subjects on an energy restricted diet: a double blind trial. Int J Obes Relat Metab Disord. 1992;16:269-277.
10. Pasquali R, Cesari MP, Melchionda N, Stefanini C, Raitano A, Labo G. Does ephedrine promote weight loss in low-energy-adapted obese women? Int J Obes. 1987;11:163-168.
11. Boozer CN, Nasser JA, Heymsfield SB, Wang V, Chen G, Solomon JL. An herbal supplement containing Ma Huang-Guarana for weight loss: a randomized, double-blind trial. Int J Obes Relat Metab Disord. 2001;25:316-324.
12. Drew CD, Knight GT, Hughes DT, Bush M. Comparison of the effects of D-(-)-ephedrine and L-(+)-pseudoephedrine on the cardiovascular and respiratory systems in man. Br J Clin Pharmacol. 1978;6:221-225.
13. United States General Accounting Office. Statement of Janet Heinrich, Director of Health Care - Public Health Issues. Dietary Supplements for Weight Loss: Limited Federal Oversight Has Focused More on Marketing Than on Safety. Washington, DC: US General Accounting Office; 2002. Report No. GAO-02-985T.
14. Boozer CN, Daly PA, Homel P, et al. Herbal ephedra/caffeine for weight loss: a 6-month randomized safety and efficacy trial. Int J Obes Relat Metab Disord. 2002;26:593-604.
15. Nadir A, Agrawal S, King PD, Marshall JB. Acute hepatitis associated with the use of a Chinese herbal product, ma-huang. Am J Gastroenterol. 1996;91:1436-1438.
16. Powell T, Hsu FF, Turk J, Hruska K. Ma-huang strikes again: ephedrine nephrolithiasis. Am J Kidney Dis. 1998;32:153-159.
17. Vahedi K, Domigo V, Amarenco P, Bousser MG. Ischaemic stroke in a sportsman who consumed MaHuang extract and creatine monohydrate for body building. J Neurol Neurosurg Psychiatry. 2000;68:112-113.
18. Hilts PJ. U.S. in criminal inquiry on Metabolife product. New York Times. August 16, 2002;sect C:1.